Sanofi-Aventis (SNY) | Common-Size Income Statement

See also

ˇ Show More

You have visited 10 password protected pages for free. Others contain data covered by .

Sanofi-Aventis, Common-Size Consolidated Income Statement

	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007	Dec 31, 2006
Net sales
Other revenues
Cost of sales
Gross profit	%	%	%	%	%
Research and development expenses
Selling and general expenses
Other operating income
Other operating expenses
Amortization of intangible assets
Impairment of intangible assets
Restructuring costs
Gains and losses on disposals, and litigation
Operating income	%	%	%	%	%
Cost of debt
Interest income
Cost of debt, net of cash and cash equivalents	%	%	%	%	%
Non-operating foreign exchange gains (losses)
Fair value gains (losses) on other derivatives
Unwinding of discount on provisions
Gains (losses) on disposals of financial assets
Impairment losses on financial assets, net of reversals
Other items
Net financial income (expenses)	%	%	%	%	%
Income before tax and associates and joint ventures	%	%	%	%	%
Income tax expense
Share of profit (loss) of associates and joint ventures
Net income excluding the held-for-exchange Merial business	%	%	%	%	%
Net income from the held-for-exchange Merial business
Net income	%	%	%	%	%
Net income attributable to non-controlling interests
Net income attributable to equity holders of sanofi-aventis	%	%	%	%	%